CClinicalTrials.gg
CompletedNCT05432037Updated May 7, 2024

Urdu Version of Fear Avoidance Belief Questionnaire: Reliability and Validity Study

An observational study in Low Back Pain, sponsored by Riphah International University. Completed at 1 site in Pakistan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-05-07.

Sponsored by Riphah International University · Observational

Study type
Observational
Model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
180
Ages
18 Years and older
Sex
All
01

Study summary

The study aims to translate and culturally adapt Fear Avoidance Belief Questionnaire into the Urdu language and to investigate the reliability and validity in the Pakistani population and check its correlation with Visual Analog Scale , Ronald Morris Questionnaire, Quebec Back Pain Disability Scale and Hospital Anxiety and Depression scale .

Read the detailed description

As per preceding commendation, Fear Avoidance Belief Questionnaire will be translated into Urdu language from its English version and adapted culturally in Pakistan. Among low back pain population, Fear Avoidance Belief Questionnaire will be conducted in 180 patients recruited by convenience sampling technique under the pre-defined inclusion and exclusion criteria after signing consents forms. For testing inter-observer reliability and intra-observer reliability of Fear Avoidance Belief Questionnaire, Hospital anxiety and depression scale, Ronald Morris questionnaire, Quebec pain rating scale and numeric pain rating scale will be administrated by two observers, on the same day, with a time interval of 2 hours between 1st and 2nd conduction. As for the 3rd conduction, it will be carried out after seven days by the first observer, for intra-observer assessment. Statistical Package of Social Sciences software version 24 will be used for the purpose of data entry and analysis. Internal consistency will be assessed by using an intra-class correlation coefficient. The Fear Avoidance Belief Questionnaire will be evaluated for content validity, construct validity, criterion validity and responsiveness.

02

Conditions studied

  • Low Back Pain

Keywords

  • Fear Avoidance Belief Questionnaire
  • Urdu Version
  • Reliability
  • Validity
  • Low Back Pain
03

In context

Back Pain

2,373 studies on the registry are indexed under Back Pain; 284 are open to participants now.

This study's enrollment of 180 is above the median of 100 across 357 observational studies indexed under Back Pain.

Browse Back Pain studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,133 studies on the registry; 633 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Target population for this study will be reported cases of low back pain.

Inclusion criteria

  • Patients or the ones next to them who gave informed consent
  • Participants with complain of low back pain for more than 3 months.
  • Age at least above 18 years.

Exclusion criteria

Exclusion Criteria:

  • Inability to understand or follow the instructions of the Fear Avoidance Belief Questionnaire.
  • Any musculoskeletal pathologies
  • Suffering from any cardiovascular pathologies
  • Any history of tumor and cancer
  • Any history of fracture
  • Any histories of infections
  • Any history of neurological disorders
  • Having any spinal deformity
05

Study design

Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
180 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Fear Avoidance Belief Questionnaire

    The fear avoidance belief questionnaire is a standardized clinical assessment tool to investigate patients work and activity specific fear-avoidance beliefs and physical disability related to work. The Fear Avoidance Belief Questionnaire consists of 2 sub-scales. The Physical Activity sub-scale and The Work sub-scale.

    Time frame: 1st day

  2. Hospital Anxiety and Depression scale

    It is the scale used for evaluation of anxiety and depression symptoms related to disease. The Hospital Anxiety and Depression scale is the objective assessment of disease related anxiety and depression symptoms based on 14 items. 7 questions for each depression and anxiety sub-scales. Scoring ranges from 0-3. Total scores are from 0-21. Normal or no anxiety scores from 0-7, 8-10 mild to moderate anxiety, 11-21 moderate to severe anxiety.

    Time frame: 1st day

  3. Ronald Morris Questionnaire

    Ronald Morris Questionnaire is the scale used for evaluation of level of disability among patients of back pain. Ronald Morris questionnaire is a self-administrated disability measurement based on 24 items. Higher level of disability is represented by greater score on 24-points scale.

    Time frame: 1st day

  4. Quebec Pain Rating Scale

    The Quebec Back Pain Disability Scale is a 20-item self-administered device designed to assess the level of practical disability in people with low back pain. The scale is a reliable and accurate measure used to monitor the progress of individual patients participating in treatment or rehabilitation programs.

    Time frame: 1st day

  5. Visual Analog Scale

    Scores of Visual Analog Scale are based on self-reported measures of symbols that are recorded with a length of 10 as well as a written mark placed in one place. The centimetre line that represents the continuity between the two ends of the scale - from "no pain" on the left end of the scale (0 cm) and the "worst pain" on the right end of the scale (10 cm).

    Time frame: 1st day

07

Study locations

1 site
  • Ripah International University
    Faisalabad, Punjab 38000, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 7, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05432037
Lead sponsor
Riphah International University
Responsible party
Sponsor
First posted
Jun 27, 2022
Start date
May 30, 2021
Primary completion
Jul 10, 2023
Completion
Jul 12, 2023
Last update
May 7, 2024

Study contacts

Muhammad Kashif
study chair · Riphah International University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion